Animal cells reversibly permeable to small molecules.
A cell preparation, useful for studying the regulation of metabolism, was developed by making monolayer baby hamster kidney cells permeable. Hypertonically treated cells were permeable to nucleotides, but retained their gross cellular morphology, intact organelles, 100% of their DNA, and 91% of their total protein. The permeable cell synthesized DNA, RNA, and protein rapidly when supplied with the appropriate substrates and cofactors. They either could remain permeable or were able to "reseal" when replaced in complete medium under appropriate conditions. Optimal conditions for DNA synthesis were established for permeable cells, giving rates equal to those of intact cells. Replication rather than repair was shown by the cell-cycle dependence of DNA synthesis and its discontinuous nature. Ribonucleotide reductase was active in permeable cells, permitting equal rates of DNA synthesis when ribonucleotide diphosphates or deoxyribonucleotide triphosphates were provided. Hydroxyurea did not inhibit DNA synthesis in permeable cells supplied with deoxyribonucleotide di- or triphosphates, but drastically inhibited DNA synthesis when ribonucleotide diphosphates were supplied. Hydroxyurea is therefore primarily an inhibitor of ribonucleotide reductase. Permeability was reversed, exposing permeable cells to [(3)H]thymidine triphosphate, which was incorporated, which labeled nuclei of cells that went on to mitosis. The reversible permeability procedure should prove especially useful in studying the functions of poorly penetrating compounds, such as drugs. Intact cells were unaffected by cytosine arabinoside triphosphate, while cells that had been made permeable and resealed were killed.
D002453:Cell Cycle; D002460:Cell Line; D002463:Cell Membrane Permeability / Q000187:drug effects*; D003561:Cytarabine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis*; D004261:DNA Replication / Q000187:drug effects; D003854:Deoxyribonucleotides / Q000378:metabolism; D006918:Hydroxyurea / Q000494:pharmacology; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors; D012462:Saline Solution, Hypertonic / Q000494:pharmacology
D003854:Deoxyribonucleotides; D012462:Saline Solution, Hypertonic; D003561:Cytarabine; D012313:RNA; D004247:DNA; D012264:Ribonucleotide Reductases; D006918:Hydroxyurea
Nature. 1965 Apr 3;206:93
14334364
J Biol Chem. 1964 Nov;239:3834-42
14257616
J Biol Chem. 1961 Sep;236:2514-9
13740427
J Biol Chem. 1951 Nov;193(1):265-75
14907713
Exp Cell Res. 1977 Jan;104(1):207-13
836402
Biochim Biophys Acta. 1973 Sep 7;319(3):336-47
4795783
J Mol Biol. 1971 Jun 28;58(3):739-53
4933426
Annu Rev Genet. 1975;9:245-84
55095
Biochemistry. 1975 Sep 23;14(19):4233-7
241375
J Biol Chem. 1974 Oct 25;249(20):6434-8
4472692
J Biol Chem. 1975 Jun 10;250(11):4348-54
165198
Exp Cell Res. 1974 Mar 15;84(1):311-8
4817725
J Biol Chem. 1966 Nov 25;241(22):5419-27
4959363
Proc Natl Acad Sci U S A. 1970 Oct;67(2):674-81
4943178
Exp Cell Res. 1976 Jul;100(2):265-75
939252
J Mol Biol. 1975 Dec 5;99(2):317-37
1206707
Biochim Biophys Acta. 1975 Feb 10;378(3):344-53
1115784
Biochim Biophys Acta. 1968 Jul 23;161(2):455-68
5667292
Science. 1966 Dec 30;154(3757):1662-5
5924199